Encision Inc. (ECIA)
OTCMKTS: ECIA · Delayed Price · USD
0.367
0.00 (0.00%)
Apr 29, 2024, 9:30 AM EDT - Market closed
Encision Revenue
Encision had revenue of $6.87M in the twelve months ending December 31, 2023, down -3.92% year-over-year. Revenue in the quarter ending December 31, 2023 was $1.58M, a -6.08% decrease year-over-year. In the fiscal year ending March 31, 2023, Encision had annual revenue of $7.35M, a decrease of -4.16%.
Revenue (ttm)
$6.87M
Revenue Growth
-3.92%
P/S Ratio
0.63
Revenue / Employee
$221,502
Employees
31
Market Cap
4.32M USD
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Mar 31, 2023 | 7.35M | -319.00K | -4.16% |
Mar 31, 2022 | 7.67M | 130.00K | 1.72% |
Mar 31, 2021 | 7.54M | -132.00K | -1.72% |
Mar 31, 2020 | 7.67M | -1.13M | -12.87% |
Mar 31, 2019 | 8.80M | 48.46K | 0.55% |
Mar 31, 2018 | 8.75M | -116.00K | -1.31% |
Mar 31, 2017 | 8.87M | -466.00K | -4.99% |
Mar 31, 2016 | 9.34M | -335.00K | -3.46% |
Mar 31, 2015 | 9.67M | -875.64K | -8.30% |
Mar 31, 2014 | 10.55M | -1.22M | -10.37% |
Mar 31, 2013 | 11.77M | -1.22M | -9.41% |
Mar 31, 2012 | 12.99M | 1.37M | 11.81% |
Mar 31, 2011 | 11.62M | -1.22M | -9.50% |
Mar 31, 2010 | 12.84M | 46.71K | 0.37% |
Mar 31, 2009 | 12.79M | 723.63K | 6.00% |
Mar 31, 2008 | 12.07M | 1.06M | 9.59% |
Mar 31, 2007 | 11.01M | 1.88M | 20.63% |
Mar 31, 2006 | 9.13M | 1.07M | 13.33% |
Mar 31, 2005 | 8.05M | 767.76K | 10.54% |
Mar 31, 2004 | 7.29M | 473.66K | 6.95% |
Mar 31, 2003 | 6.81M | 1.95M | 40.06% |
Mar 31, 2002 | 4.86M | 1.85M | 61.20% |
Mar 31, 2001 | 3.02M | 1.02M | 50.71% |
Mar 31, 2000 | 2.00M | 433.69K | 27.65% |
Mar 31, 1999 | 1.57M | 252.51K | 19.19% |
Mar 31, 1998 | 1.32M | -82.27K | -5.88% |
Mar 31, 1997 | 1.40M | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 371.62B |
Johnson & Johnson | 81.80B |
Merck & Co. | 60.12B |
AbbVie | 54.32B |
Novartis AG | 49.92B |
AstraZeneca | 47.61B |
Thermo Fisher | 42.86B |
Abbott Laboratories | 40.11B |
ECIA News
- 2 months ago - Encision Reports Third Quarter Fiscal Year 2024 Results - Accesswire
- 6 months ago - Encision Reports Second Quarter Fiscal Year 2024 Results - Accesswire
- 9 months ago - Encision Reports First Quarter Fiscal Year 2024 Results - Accesswire
- 11 months ago - Encision Reports Fourth Quarter Fiscal Year 2023 Results - Accesswire
- 1 year ago - Encision Signs Supplier Agreement with Human Xtensions - Accesswire
- 1 year ago - Encision Signs Proof of Concept Agreement with Vicarious Surgical Inc. - Accesswire
- 1 year ago - Encision Reports Third Quarter Fiscal Year 2023 Results - Accesswire
- 1 year ago - Encision Reports Second Quarter Fiscal Year 2023 Results - Accesswire